Review



dhplc wave nucleic acid fragment analyzer system model 3500ht  (Transgenomic)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Transgenomic dhplc wave nucleic acid fragment analyzer system model 3500ht
    <t>dHPLC</t> and reverse sequence results that demonstrate the CHEK2 1100delC variant in the two patients. Both patients were <t>heterozygous</t> <t>mutation</t> carriers. The heteroduplex formations are seen as extra peaks in the dHPLC chromatogram.
    Dhplc Wave Nucleic Acid Fragment Analyzer System Model 3500ht, supplied by Transgenomic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhplc+wave+nucleic+acid+fragment+analyzer+system+model+3500ht/3500ht+wave+dna+fragment+analysis+system/pmc01421428-42-6-7
    Average 90 stars, based on 1 article reviews
    dhplc wave nucleic acid fragment analyzer system model 3500ht - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum"

    Article Title: CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum

    Journal: BMC Cancer

    doi: 10.1186/1471-2407-6-64

    dHPLC and reverse sequence results that demonstrate the CHEK2 1100delC variant in the two patients. Both patients were heterozygous mutation carriers. The heteroduplex formations are seen as extra peaks in the dHPLC chromatogram.
    Figure Legend Snippet: dHPLC and reverse sequence results that demonstrate the CHEK2 1100delC variant in the two patients. Both patients were heterozygous mutation carriers. The heteroduplex formations are seen as extra peaks in the dHPLC chromatogram.

    Techniques Used: Sequencing, Variant Assay, Mutagenesis

    Related Articles

    Mutagenesis:

    Article Title: CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Article Snippet: Mutation analysis was carried out using dHPLC (Transgenomic WAVE Nucleic Acid Fragment Analyzer System Model 3500HT) and samples with aberrant patterns were further analyzed by direct sequencing (Terminator Cycle Sequencing Reaction Kits version 3.1, ABI Prism 3100 Genetic Analyzer; Applied Biosystems).

    Sequencing:

    Article Title: CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Article Snippet: Mutation analysis was carried out using dHPLC (Transgenomic WAVE Nucleic Acid Fragment Analyzer System Model 3500HT) and samples with aberrant patterns were further analyzed by direct sequencing (Terminator Cycle Sequencing Reaction Kits version 3.1, ABI Prism 3100 Genetic Analyzer; Applied Biosystems).

    Variant Assay:

    Article Title: CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum
    Article Snippet: Mutation analysis was carried out using dHPLC (Transgenomic WAVE Nucleic Acid Fragment Analyzer System Model 3500HT) and samples with aberrant patterns were further analyzed by direct sequencing (Terminator Cycle Sequencing Reaction Kits version 3.1, ABI Prism 3100 Genetic Analyzer; Applied Biosystems).



    Similar Products

    dhplc wave nucleic acid fragment analyzer system model 3500ht  (Transgenomic)
    90
    Transgenomic dhplc wave nucleic acid fragment analyzer system model 3500ht
    <t>dHPLC</t> and reverse sequence results that demonstrate the CHEK2 1100delC variant in the two patients. Both patients were <t>heterozygous</t> <t>mutation</t> carriers. The heteroduplex formations are seen as extra peaks in the dHPLC chromatogram.
    Dhplc Wave Nucleic Acid Fragment Analyzer System Model 3500ht, supplied by Transgenomic, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dhplc+wave+nucleic+acid+fragment+analyzer+system+model+3500ht/3500ht+wave+dna+fragment+analysis+system/pmc01421428-42-6-7
    Average 90 stars, based on 1 article reviews
    dhplc wave nucleic acid fragment analyzer system model 3500ht - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    dHPLC and reverse sequence results that demonstrate the CHEK2 1100delC variant in the two patients. Both patients were heterozygous mutation carriers. The heteroduplex formations are seen as extra peaks in the dHPLC chromatogram.

    Journal: BMC Cancer

    Article Title: CHEK2 1100delC in patients with metachronous cancers of the breast and the colorectum

    doi: 10.1186/1471-2407-6-64

    Figure Lengend Snippet: dHPLC and reverse sequence results that demonstrate the CHEK2 1100delC variant in the two patients. Both patients were heterozygous mutation carriers. The heteroduplex formations are seen as extra peaks in the dHPLC chromatogram.

    Article Snippet: Mutation analysis was carried out using dHPLC (Transgenomic WAVE Nucleic Acid Fragment Analyzer System Model 3500HT) and samples with aberrant patterns were further analyzed by direct sequencing (Terminator Cycle Sequencing Reaction Kits version 3.1, ABI Prism 3100 Genetic Analyzer; Applied Biosystems).

    Techniques: Sequencing, Variant Assay, Mutagenesis